# Prospective Randomized Study of Nasal High Flow in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

> **NCT02439333** · NA · COMPLETED · sponsor: **Li Xuyan** · enrollment: 320 (actual)

## Conditions studied

- Lung Diseases, Obstructive

## Interventions

- **DEVICE:** Nasal high flow cannula (Fisher & Paykel Healthcare, Auckland, New Zealand)
- **DEVICE:** nasal catheter or Venturi mask

## Key facts

- **NCT ID:** NCT02439333
- **Lead sponsor:** Li Xuyan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2019-07
- **Final completion:** 2019-07-15
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02439333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02439333, "Prospective Randomized Study of Nasal High Flow in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02439333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*